China aims to ‘lead the world’ by winning the coronavirus vaccine race
The Modesto Bee,
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls putting…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls putting…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
By ALICE SU Los Angeles Times June 17, 2020 04:00 AM, They weren't just vaccine volunteers.
BEIJING They weren't just vaccine volunteers. They were "revolutionary comrades in arms," nearly 200 mostly young, brave souls…
BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis.
A Chinese biotech has announced positive early results of a vaccine against the coronavirus, claiming it induced an immune…
A Chinese biotech has announced positive early results of a vaccine against the coronavirus, claiming it induced an immune…
Developing a vaccine is difficult at the best of times, but rarely have we been in a situation where basic knowledge about a…
Click here to read the full original article. Developing a vaccine is difficult at the best of times, but rarely have we been…
Developing a vaccine is difficult at the best of times, but rarely have we been in a situation where basic knowledge about a…
Virologist explains what we know about two promising coronavirus vaccines so far - and how much more we still need to know…
Developing a vaccine is difficult at the best of times, but rarely have we been in a situation where basic knowledge about a…
Developing a vaccine is difficult at the best of times, but rarely have we been in a situation where basic knowledge about a…
La première étude scientifique sur un vaccin contre la Covid-19, mis au point par la biotech chinoise CanSino Biologics, montre…
Manoj Joshi Distinguished fellow, Observer Research Foundation, New Delhi EVEN as the US is tightening the screws on China on…
Azért arra figyelmeztetnek, hogy korai még biztosra menni a megelőzést illetően.
A promising coronavirus vaccine candidate cleared a key hurdle this week, when Moderna Therapeutics entered phase two of…
Advertisement There are currently two promising candidates that are providing us with encouraging early data while numerous…
Den första patientstudien med ett vaccin mot covid-19 har nu granskats och publicerats i en vetenskaplig tidskrift.
Article By The China National Intellectual Property Administration published on June 2, 2020 what may be the first patent…
Koronarokote ei ole ainakaan yrittämisestä kiinni. Paraikaa yliopistojen ja yritysten tutkijat ympäri maailman kehittävät…
Andrew Azman, PhD, assistant scientist, department of epidemiology, Johns Hopkins University Bloomberg School of Public Health.
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for May 2020.
Here are what the editors at HealthDay consider to be the most important developments in Nursing for May 2020.
Here are what the editors at HealthDay consider to be the most important developments in Pathology for May 2020.
Here are what the editors at HealthDay consider to be the most important developments in Critical Care for May 2020.
I ricercatori impegnati nello sviluppo di vaccini per il nuovo coronavirus vogliono proteggere i pazienti senza però innescare…
Video above: Moderna announces 'positive' early results in coronavirus vaccine trial Moderna set off a frenzy on Wall Street…
Video above: Moderna announces 'positive' early results in coronavirus vaccine trialModerna set off a frenzy on Wall Street…
iStock image The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to…
Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary results from its coronavirus…
https://cdn.cnn.com/cnnnext/dam/assets/200529124421-01-moderna-lab-file-super-tease.jpg Days later, Moderna’s leading…
Die Welt sitzt auf glühenden Kohlen. Antworten auf die wichtigsten Fragen rund um einen künftigen Schutz vor Sars-Cov-2.
New York (CNN Business)Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary…
New York (CNN Business)Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary…
New York (CNN Business)Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary…
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2020.
[Photo/cansinotech.com.cn] A potential coronavirus vaccine developed in China appeared safe and able to generate an immune…
While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach…
Get short URL https://cdn1.img.sputniknews.com/img/107943/62/1079436262_0:198:3291:2048_1200x675_80_0_0_e32eaa19e86a53c4433d41780…
A promising coronavirus vaccine candidate cleared a key hurdle this week, when Moderna Therapeutics entered phase two of…
A promising coronavirus vaccine candidate cleared a key hurdle this week, when Moderna Therapeutics entered phase two of…
Таковы итоги первой фазы клинических испытаний, проведенных исследователями из Китая.
(HealthDay News) — A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic…
Special: Battle Against Novel Coronavirus A potential coronavirus vaccine developed in China appeared safe and able to generate…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
– By Jeremy Rossman, Honorary Senior Lecturer in Virology and President of Research-Aid Networks, University of Kent While no…
While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach…
While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach…
While no country claims to be pursuing herd immunity as a strategy, some – such as Sweden – have taken a more relaxed approach…
Credit: CanSino Each vial of CanSino’s experimental COVID-19 vaccine contains 50 billion engineered adenoviruses.
The coronavirus pandemic has provided the world with a quick study in the intricacies of immunology.
© CC0 / ulleo Un professeur israélien a mis en garde contre toute précipitation dans la généralisation du vaccin contre le…
Researchers from China report the initial findings of the first human trial for a potential vaccine against SARS-CoV-2, the new…
A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial…
Scientists across the globe are racing to develop a vaccine that can provide protection against coronavirus disease (COVID-19).
© Foto : Pixabay / TheDigitalArtist El Gobierno español está trabajando para que el país pueda albergar los ensayos clínicos de…
Desde diferentes lugares del mundo surgen investigaciones en busca de una vacuna eficaz para prevenir el coronavirus, así como…
世界中の研究所や企業が総力をあげて新型コロナウイルス(SARS-CoV-2)ワクチンの研究開発を進めており、すでに臨床試験の段階に進んでいるものも存在しています。中国の研究チームが「開発中のSARS-CoV-2ワクチンの臨床試験で、抗体の生成が確認された」と…
Scientists have moved forward in developing an effective vaccine for COVID-19. A team in China found one candidate that…
(Reuters) - A coronavirus vaccine tested for the first time in humans is safe and induces a rapid immune response, researchers…
Compiled by veteran medical journalist Brian Owens, this roundup of some of the newest science on the COVID-19 pandemic…
Health
Prolongar / Doses de teste de outra vacina potencial contra SARS-CoV-2. MLADEN ANTONOV / Cobertura Covid-19 Ver mais histórias…
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe, tolerable, and immunogenic, according to a study published…
(HealthDay News) -- A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic…
A recombinant adenovirus type 5 vectored vaccine against coronavirus disease 2019 (COVID-19) was found to be well tolerated and…
Die Zahl der gemeldeten Infektionen mit dem neuartigen Coronavirus, das von der Weltgesundheitsorganisation WHO den offiziellen…
-- A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic, according to a study…
Auch wenn die Ansteckungszahlen mit Sars-CoV-2 in Teilen der Welt nicht mehr sprunghaft ansteigen, arbeiten Forscher weltweit…
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well tolerated and able to generate an…
The study on 108 adults found that one dose of the vaccine known as recombinant adenovirus type-5 vectored Covid-19 vaccine (AD5…
The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune…
The search for a new vaccine The vaccine, which has been developed in China has shown good effective results and if reports are…
First human trial of COVID-19 vaccine found to be safe and effective About a dozen experimental vaccines are in early stages of…
26-May-2020 Intellasia | South China Morning Post | 6:02 AM A potential Covid-19 vaccine developed by Chinese top military…
Новую китайскую вакцину от коронавируса Ad5-nCoV успешно протестировали на добровольцах: вакцина вызывала быстрый иммунный ответ…
Innerhalb einer Woche hat nun das zweite Forscherteam die Ergebnisse einer Phase-I-Studie zu einem Covid-19-Impfstoff veröffentli…
Contro il SARS-CoV-2, che provoca la malattia da coronavirus, la COVID-19, c'è un potenziale vaccino, prodotto dall'azienda di…
/Andreas Prott, stock.adobe.com Peking − Nach einem US-amerikanischen hat jetzt auch ein chinesischer Impfstoffentwickler…
Ad5-nCoV Mit Ad5-nCoV zeigt ein weiterer Phase-I-Impfstoffkandidat gegen das neue Coronavirus erste Erfolge.
Numa conversa por vídeo dias atrás, o infectologista Esper Kallás, da Faculdade de Medicina da USP, soltou uma pergunta…
The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune…